News · Japan
Oracle and Eclevar drive success for medical device corporations in Japan.
Japan’s medical device market is expanding rapidly. Eclevar MedTech, working with Oracle’s clinical trial technology, helps manufacturers navigate its unique regulatory and compliance pathways.
The Japanese market for medical devices is expanding rapidly, presenting significant opportunities for pharmaceutical and medical device companies. Japan’s aging population, its history of adopting new medical technologies, and the pandemic’s acceleration of digital methods all drive demand for advanced medical technologies. However, regulatory compliance in Japan is unique, and navigating its pathways can be challenging.
The right partners
To achieve successful outcomes in Japan, working with the right partners matters. ECLEVAR MEDTECH has been an expert in working with significant KOLs and navigating complex regulatory environments for several decades, while Oracle brings next-generation clinical trial technology. Eclevar joined a panel of industry experts at Oracle’s Innovation Series webinar, “Creating the Future in Clinical Research with CROs using Real-World Data.”
Meet the team
To grow into the Japanese market with a long-term clinical strategy, Eclevar has been available to discuss opportunities at industry events including Medtec Japan (19–21 April 2023).
Expanding into the Japanese medtech market?
Talk to Eclevar MedTech about clinical strategy and regulatory navigation in Japan.
Book a free scoping call